Systematic analysis of COVID-19 mRNA vaccines using four orthogonal approaches demonstrates no excessive DNA impurities

preprint OA: closed CC-BY-4.0
📄 Open PDF Full text JSON View at publisher
AI-generated deep summary by claude@2026-06, 2026-06-24 · read from full text

This study examined residual DNA quantity, quality, and identity in 15 production batches of two COVID-19 mRNA vaccines (Comirnaty and Spikevax) obtained from official Slovak repositories, using four orthogonal analytical methods: qPCR, fluorometry, capillary electrophoresis, and short-read DNA sequencing. The authors report that across all batches— including 11 previously alleged to contain “significant amounts of DNA”— residual DNA levels were below approved limits, present in very low amounts relative to mRNA, and degraded into small fragments consistent with DNA template origins from transcription during manufacturing. A key limitation they emphasize is that prior claims were based on improperly performed reverse-transcription multiplex qPCR, and that reliable assessment requires rigorous, method-compliant analysis that minimizes interference among mRNA vaccine components. The paper does not explicitly discuss endometriosis or adenomyosis; it was included in the corpus via a keyword match in the upstream search index.

Read from the paper's body, not the abstract. Not a substitute for reading the paper. No clinical advice. How this works

Abstract

Abstract Robust epidemiologic data confirm that vaccination saved millions of lives and protected recipients from severe COVID-19 disease caused by SARS-CoV-2 infection. Despite this evidence, COVID-19 mRNA vaccines have become a target of largely unfounded skepticism built on coincidental health events occurring after vaccination without proven causality. An example of claims undermining trust in mRNA vaccine safety relates to excessive amounts of residual DNA from the vaccine manufacturing process. These claims are based on improperly accomplished quantification methods and/or incorrectly interpreted data. In this study, we aimed to thoroughly assess quantity, quality and identity of residual DNA in mRNA vaccines based on objective, technically correctly performed and interpreted methods using orthogonal approaches, including qPCR, fluorometry, capillary electrophoresis and short-read DNA sequencing. We analysed 15 batches of Comirnaty and Spikevax vaccines available in Slovakia, obtained from official repositories under the supervision of the State Institute for Drug Control. These included 11 batches post-expiration date that were previously claimed by others to contain “significant amounts of DNA” using data from reverse transcription-based multiplex qPCR performed with technical shortcomings. Results of our analyses utilising four orthogonal approaches clearly demonstrate that the quantity of residual DNA in all analysed vaccine batches is below approved limits, in very low quantities relative to mRNA, and degraded into small fragments, which originate from the DNA template used to transcribe mRNA during vaccine production. Our results show that reliable vaccine analysis requires rigorous application of multiple validated methods that comply with molecular characteristics of mRNA vaccine components and minimise their mutual interference.
Full text 20,596 characters · extracted from preprint-html · click to expand
Systematic analysis of COVID-19 mRNA vaccines using four orthogonal approaches demonstrates no excessive DNA impurities | Research Square window.SnipcartSettings = { analytics: { enabled: false } }; (function() { var accessVector = localStorage.getItem('access_vector') || ''; window.dataLayer = window.dataLayer || []; if (accessVector) { window.dataLayer.push({ user: { profile: { profileInfo: { snid: accessVector } } } }); } })(); (function(w,d,s,l,i){w[l]=w[l]||[];w[l].push({'gtm.start':new Date().getTime(),event:'gtm.js'});var f=d.getElementsByTagName(s)[0],j=d.createElement(s),dl=l!='dataLayer'?'&l='+l:'';j.async=true;j.src='https://www.googletagmanager.com/gtm.js?id='+i+dl;f.parentNode.insertBefore(j,f);})(window,document,'script','dataLayer','GTM-K279D39R'); Browse Preprints In Review Journals COVID-19 Preprints AJE Video Bytes Research Tools Research Promotion AJE Professional Editing AJE Rubriq About Preprint Platform In Review Editorial Policies Our Team Advisory Board Help Center Sign In Submit a Preprint Cite Share Download PDF Article Systematic analysis of COVID-19 mRNA vaccines using four orthogonal approaches demonstrates no excessive DNA impurities Adam Achs, Tatiana Sedlackova, Lukas Predajna, Jaroslav Budis, and 11 more This is a preprint; it has not been peer reviewed by a journal. https://doi.org/ 10.21203/rs.3.rs-7340318/v1 This work is licensed under a CC BY 4.0 License Status: Published Journal Publication published 13 Dec, 2025 Read the published version in npj Vaccines → Version 1 posted 18 You are reading this latest preprint version Abstract Robust epidemiologic data confirm that vaccination saved millions of lives and protected recipients from severe COVID-19 disease caused by SARS-CoV-2 infection. Despite this evidence, COVID-19 mRNA vaccines have become a target of largely unfounded skepticism built on coincidental health events occurring after vaccination without proven causality. An example of claims undermining trust in mRNA vaccine safety relates to excessive amounts of residual DNA from the vaccine manufacturing process. These claims are based on improperly accomplished quantification methods and/or incorrectly interpreted data. In this study, we aimed to thoroughly assess quantity, quality and identity of residual DNA in mRNA vaccines based on objective, technically correctly performed and interpreted methods using orthogonal approaches, including qPCR, fluorometry, capillary electrophoresis and short-read DNA sequencing. We analysed 15 batches of Comirnaty and Spikevax vaccines available in Slovakia, obtained from official repositories under the supervision of the State Institute for Drug Control. These included 11 batches post-expiration date that were previously claimed by others to contain “significant amounts of DNA” using data from reverse transcription-based multiplex qPCR performed with technical shortcomings. Results of our analyses utilising four orthogonal approaches clearly demonstrate that the quantity of residual DNA in all analysed vaccine batches is below approved limits, in very low quantities relative to mRNA, and degraded into small fragments, which originate from the DNA template used to transcribe mRNA during vaccine production. Our results show that reliable vaccine analysis requires rigorous application of multiple validated methods that comply with molecular characteristics of mRNA vaccine components and minimise their mutual interference. Biological sciences/Biological techniques Biological sciences/Biotechnology Health sciences/Diseases Biological sciences/Genetics Biological sciences/Immunology Biological sciences/Microbiology Biological sciences/Molecular biology mRNA vaccine residual DNA qPCR fluorometry capillary electrophoresis fragment analysis short-read DNA sequencing Full Text Supplementary Files MSAchsetalSUPPLEMENTARYINFORMATION.pdf Cite Share Download PDF Status: Published Journal Publication published 13 Dec, 2025 Read the published version in npj Vaccines → Version 1 posted Editorial decision: Revision requested 28 Sep, 2025 Reviews received at journal 23 Sep, 2025 Reviews received at journal 23 Sep, 2025 Reviews received at journal 23 Sep, 2025 Reviews received at journal 21 Sep, 2025 Reviewers agreed at journal 07 Sep, 2025 Reviewers agreed at journal 07 Sep, 2025 Reviews received at journal 05 Sep, 2025 Reviewers agreed at journal 04 Sep, 2025 Reviewers agreed at journal 04 Sep, 2025 Reviewers agreed at journal 03 Sep, 2025 Reviewers agreed at journal 02 Sep, 2025 Reviewers agreed at journal 02 Sep, 2025 Reviewers agreed at journal 02 Sep, 2025 Reviewers invited by journal 24 Aug, 2025 Editor assigned by journal 21 Aug, 2025 Submission checks completed at journal 14 Aug, 2025 First submitted to journal 10 Aug, 2025 You are reading this latest preprint version Research Square lets you share your work early, gain feedback from the community, and start making changes to your manuscript prior to peer review in a journal. As a division of Research Square Company, we’re committed to making research communication faster, fairer, and more useful. We do this by developing innovative software and high quality services for the global research community. Our growing team is made up of researchers and industry professionals working together to solve the most critical problems facing scientific publishing. Also discoverable on Platform About Our Team In Review Editorial Policies Advisory Board Help Center Resources Author Services Accessibility API Access RSS feed Manage Cookie Preferences © Research Square 2026 | ISSN 2693-5015 (online) Privacy Policy Terms of Service Do Not Sell My Personal Information {"props":{"pageProps":{"initialData":{"identity":"rs-7340318","acceptedTermsAndConditions":true,"allowDirectSubmit":false,"archivedVersions":[],"articleType":"Article","associatedPublications":[],"authors":[{"id":507655602,"identity":"7d1c3565-7b73-4a00-a4be-170c29983803","order_by":0,"name":"Adam Achs","email":"","orcid":"","institution":"Biomedical Research Center, Slovak Academy of Sciences, Institute of Virology","correspondingAuthor":false,"prefix":"","firstName":"Adam","middleName":"","lastName":"Achs","suffix":""},{"id":507655603,"identity":"291bad0b-3279-4dc9-a39f-82b9bf8477e8","order_by":1,"name":"Tatiana Sedlackova","email":"","orcid":"","institution":"Comenius University Science Park","correspondingAuthor":false,"prefix":"","firstName":"Tatiana","middleName":"","lastName":"Sedlackova","suffix":""},{"id":507655604,"identity":"ef7d665d-327e-4f46-8668-692b7e4de535","order_by":2,"name":"Lukas Predajna","email":"","orcid":"","institution":"Biomedical Research Center, Slovak Academy of Sciences, Institute of Virology","correspondingAuthor":false,"prefix":"","firstName":"Lukas","middleName":"","lastName":"Predajna","suffix":""},{"id":507655605,"identity":"510a2599-1592-4021-9eff-1466c1fea815","order_by":3,"name":"Jaroslav Budis","email":"","orcid":"","institution":"Comenius University Science Park","correspondingAuthor":false,"prefix":"","firstName":"Jaroslav","middleName":"","lastName":"Budis","suffix":""},{"id":507655606,"identity":"53a60b9e-6124-47fb-8da2-bb504372f081","order_by":4,"name":"Maria Bartosova","email":"","orcid":"","institution":"Biomedical Research Center, Slovak Academy of Sciences, Institute of Virology","correspondingAuthor":false,"prefix":"","firstName":"Maria","middleName":"","lastName":"Bartosova","suffix":""},{"id":507655607,"identity":"14a36f36-fecb-44c4-a1a3-3fe3e1bd5bc9","order_by":5,"name":"Vladimir Zelnik","email":"","orcid":"","institution":"Biomedical Research Center, Slovak Academy of Sciences, Biotechnological and Analytical Laboratories","correspondingAuthor":false,"prefix":"","firstName":"Vladimir","middleName":"","lastName":"Zelnik","suffix":""},{"id":507655608,"identity":"2aff26a9-8c14-40cd-955c-df38521c9436","order_by":6,"name":"Diana Rusnakova","email":"","orcid":"","institution":"Comenius University Science Park","correspondingAuthor":false,"prefix":"","firstName":"Diana","middleName":"","lastName":"Rusnakova","suffix":""},{"id":507655609,"identity":"2134f5f3-ce1c-4a2c-9b6d-d9abccbb2bf1","order_by":7,"name":"Martina Melichercikova","email":"","orcid":"","institution":"Biomedical Research Center, Slovak Academy of Sciences, Institute of Virology","correspondingAuthor":false,"prefix":"","firstName":"Martina","middleName":"","lastName":"Melichercikova","suffix":""},{"id":507655610,"identity":"1f2dd16f-0611-4905-af2a-7f4fc4ae579c","order_by":8,"name":"Marta Miklosova","email":"","orcid":"","institution":"Biomedical Research Center, Slovak Academy of Sciences, Biotechnological and Analytical Laboratories","correspondingAuthor":false,"prefix":"","firstName":"Marta","middleName":"","lastName":"Miklosova","suffix":""},{"id":507655612,"identity":"5b2ca075-2aca-46b2-ad27-3183d26ecc0d","order_by":9,"name":"Veronika Gencurova","email":"","orcid":"","institution":"Biomedical Research Center, Slovak Academy of Sciences, Biotechnological and Analytical Laboratories","correspondingAuthor":false,"prefix":"","firstName":"Veronika","middleName":"","lastName":"Gencurova","suffix":""},{"id":507655615,"identity":"335cac7f-1d15-4ef8-9eb2-d97ef582753e","order_by":10,"name":"Barbora Cernakova","email":"","orcid":"","institution":"Biomedical Research Center, Slovak Academy of Sciences, Biotechnological and Analytical Laboratories","correspondingAuthor":false,"prefix":"","firstName":"Barbora","middleName":"","lastName":"Cernakova","suffix":""},{"id":507655618,"identity":"b0002edd-c990-4d99-b065-a356519c5723","order_by":11,"name":"Tomas Szemes","email":"","orcid":"","institution":"Comenius University Science Park","correspondingAuthor":false,"prefix":"","firstName":"Tomas","middleName":"","lastName":"Szemes","suffix":""},{"id":507655621,"identity":"13de1198-343a-44bc-91be-76d0d85f29d6","order_by":12,"name":"Boris Klempa","email":"","orcid":"","institution":"Biomedical Research Center, Slovak Academy of Sciences, Institute of Virology","correspondingAuthor":false,"prefix":"","firstName":"Boris","middleName":"","lastName":"Klempa","suffix":""},{"id":507655624,"identity":"ffb086a0-0a04-4464-985d-8a687e008b4d","order_by":13,"name":"Juraj Kopacek","email":"","orcid":"","institution":"Biomedical Research Center, Slovak Academy of Sciences, Institute of Virology","correspondingAuthor":false,"prefix":"","firstName":"Juraj","middleName":"","lastName":"Kopacek","suffix":""},{"id":507655627,"identity":"baf110ce-1090-434b-bd62-9f7f160e3a0e","order_by":14,"name":"Silvia Pastorekova","email":"data:image/png;base64,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","orcid":"","institution":"Biomedical Research Center, Slovak Academy of Sciences, Institute of Virology","correspondingAuthor":true,"prefix":"","firstName":"Silvia","middleName":"","lastName":"Pastorekova","suffix":""}],"badges":[],"createdAt":"2025-08-10 17:38:15","currentVersionCode":1,"declarations":"","doi":"10.21203/rs.3.rs-7340318/v1","doiUrl":"https://doi.org/10.21203/rs.3.rs-7340318/v1","draftVersion":[],"editorialEvents":[{"content":"https://doi.org/10.1038/s41541-025-01304-9","type":"published","date":"2025-12-13T15:58:04+00:00"}],"editorialNote":"","failedWorkflow":false,"files":[{"id":98243734,"identity":"c4f77fd1-9b63-41e4-8cd6-b856d9b9b9b9","added_by":"auto","created_at":"2025-12-15 16:10:08","extension":"pdf","order_by":1,"title":"","display":"","copyAsset":false,"role":"manuscript-pdf","size":1480027,"visible":true,"origin":"","legend":"","description":"","filename":"MSAchsetal10082025finalversion1.pdf","url":"https://assets-eu.researchsquare.com/files/rs-7340318/v1_covered_6a0d2825-4116-42fe-959a-c64da045b685.pdf"},{"id":90347833,"identity":"f7318c4c-fd44-4843-97b3-537d29c162d1","added_by":"auto","created_at":"2025-09-01 16:44:05","extension":"pdf","order_by":0,"title":"","display":"","copyAsset":false,"role":"supplement","size":8359927,"visible":true,"origin":"","legend":"","description":"","filename":"MSAchsetalSUPPLEMENTARYINFORMATION.pdf","url":"https://assets-eu.researchsquare.com/files/rs-7340318/v1/6501b0fac3132086f1c51919.pdf"}],"financialInterests":"","formattedTitle":"Systematic analysis of COVID-19 mRNA vaccines using four orthogonal approaches demonstrates no excessive DNA impurities","fulltext":[],"fulltextSource":"","fullText":"","funders":[],"hasAdminPriorityOnWorkflow":false,"hasManuscriptDocX":false,"hasOptedInToPreprint":true,"hasPassedJournalQc":"","hasAnyPriority":false,"hideJournal":false,"highlight":"","institution":"","isAcceptedByJournal":true,"isAuthorSuppliedPdf":true,"isDeskRejected":"","isHiddenFromSearch":false,"isInQc":false,"isInWorkflow":false,"isPdf":true,"isPdfUpToDate":true,"isWithdrawnOrRetracted":false,"journal":{"display":true,"email":"[email protected]","identity":"npj-vaccines","isNatureJournal":false,"hasQc":true,"allowDirectSubmit":false,"externalIdentity":"npjvaccines","sideBox":"Learn more about [npj Vaccines](http://www.nature.com/npjvaccines/)","snPcode":"41541","submissionUrl":"https://submission.springernature.com/new-submission/41541/3?","title":"npj Vaccines","twitterHandle":"","acdcEnabled":true,"dfaEnabled":true,"editorialSystem":"stoa","reportingPortfolio":"NPJ","inReviewEnabled":true,"inReviewRevisionsEnabled":true},"keywords":"mRNA vaccine, residual DNA, qPCR, fluorometry, capillary electrophoresis, fragment analysis, short-read DNA sequencing","lastPublishedDoi":"10.21203/rs.3.rs-7340318/v1","lastPublishedDoiUrl":"https://doi.org/10.21203/rs.3.rs-7340318/v1","license":{"name":"CC BY 4.0","url":"https://creativecommons.org/licenses/by/4.0/"},"manuscriptAbstract":"\u003cp\u003eRobust epidemiologic data confirm that vaccination saved millions of lives and protected recipients from severe COVID-19 disease caused by SARS-CoV-2 infection. Despite this evidence, COVID-19 mRNA vaccines have become a target of largely unfounded skepticism built on coincidental health events occurring after vaccination without proven causality. An example of claims undermining trust in mRNA vaccine safety relates to excessive amounts of residual DNA from the vaccine manufacturing process. These claims are based on improperly accomplished quantification methods and/or incorrectly interpreted data. In this study, we aimed to thoroughly assess quantity, quality and identity of residual DNA in mRNA vaccines based on objective, technically correctly performed and interpreted methods using orthogonal approaches, including qPCR, fluorometry, capillary electrophoresis and short-read DNA sequencing. We analysed 15 batches of Comirnaty and Spikevax vaccines available in Slovakia, obtained from official repositories under the supervision of the State Institute for Drug Control. These included 11 batches post-expiration date that were previously claimed by others to contain \u0026ldquo;significant amounts of DNA\u0026rdquo; using data from reverse transcription-based multiplex qPCR performed with technical shortcomings. Results of our analyses utilising four orthogonal approaches clearly demonstrate that the quantity of residual DNA in all analysed vaccine batches is below approved limits, in very low quantities relative to mRNA, and degraded into small fragments, which originate from the DNA template used to transcribe mRNA during vaccine production. Our results show that reliable vaccine analysis requires rigorous application of multiple validated methods that comply with molecular characteristics of mRNA vaccine components and minimise their mutual interference.\u003c/p\u003e","manuscriptTitle":"Systematic analysis of COVID-19 mRNA vaccines using four orthogonal approaches demonstrates no excessive DNA impurities","msid":"","msnumber":"","nonDraftVersions":[{"code":1,"date":"2025-09-01 16:35:59","doi":"10.21203/rs.3.rs-7340318/v1","editorialEvents":[{"type":"communityComments","content":19},{"type":"decision","content":"Revision requested","date":"2025-09-28T22:28:57+00:00","index":"","fulltext":""},{"type":"editorInvitedReview","content":"","date":"2025-09-24T02:19:49+00:00","index":"hide","fulltext":""},{"type":"editorInvitedReview","content":"","date":"2025-09-23T17:07:11+00:00","index":"hide","fulltext":""},{"type":"editorInvitedReview","content":"","date":"2025-09-23T16:12:37+00:00","index":"hide","fulltext":""},{"type":"editorInvitedReview","content":"","date":"2025-09-22T01:39:35+00:00","index":"hide","fulltext":""},{"type":"reviewerAgreed","content":"121752238506844569820399504226453335523","date":"2025-09-07T23:24:58+00:00","index":"hide","fulltext":""},{"type":"reviewerAgreed","content":"115124295572489990657749591878339052311","date":"2025-09-07T22:24:25+00:00","index":"hide","fulltext":""},{"type":"editorInvitedReview","content":"","date":"2025-09-05T14:13:23+00:00","index":"hide","fulltext":""},{"type":"reviewerAgreed","content":"326003537334913207481157913910978311132","date":"2025-09-04T22:05:49+00:00","index":"hide","fulltext":""},{"type":"reviewerAgreed","content":"298115033554599609595686119399846439939","date":"2025-09-04T19:20:11+00:00","index":"hide","fulltext":""},{"type":"reviewerAgreed","content":"103762517533105720964012056483399033863","date":"2025-09-03T08:59:56+00:00","index":"hide","fulltext":""},{"type":"reviewerAgreed","content":"286710020653078488473854856266221496582","date":"2025-09-02T17:28:44+00:00","index":"hide","fulltext":""},{"type":"reviewerAgreed","content":"207473726261000215612357253360519012511","date":"2025-09-02T17:18:56+00:00","index":"hide","fulltext":""},{"type":"reviewerAgreed","content":"157269140467450589224426972807788802591","date":"2025-09-02T16:54:51+00:00","index":"hide","fulltext":""},{"type":"reviewersInvited","content":"","date":"2025-08-24T21:40:58+00:00","index":"","fulltext":""},{"type":"editorAssigned","content":"","date":"2025-08-21T17:01:52+00:00","index":"","fulltext":""},{"type":"checksComplete","content":"","date":"2025-08-14T08:00:12+00:00","index":"","fulltext":""},{"type":"submitted","content":"npj Vaccines","date":"2025-08-10T17:34:36+00:00","index":"","fulltext":""}],"status":"published","journal":{"display":true,"email":"[email protected]","identity":"npj-vaccines","isNatureJournal":false,"hasQc":true,"allowDirectSubmit":false,"externalIdentity":"npjvaccines","sideBox":"Learn more about [npj Vaccines](http://www.nature.com/npjvaccines/)","snPcode":"41541","submissionUrl":"https://submission.springernature.com/new-submission/41541/3?","title":"npj Vaccines","twitterHandle":"","acdcEnabled":true,"dfaEnabled":true,"editorialSystem":"stoa","reportingPortfolio":"NPJ","inReviewEnabled":true,"inReviewRevisionsEnabled":true}}],"origin":"","ownerIdentity":"666c63a4-8543-443a-bb79-a84e56d758c2","owner":[],"postedDate":"September 1st, 2025","published":true,"recentEditorialEvents":[],"rejectedJournal":[],"revision":"","amendment":"","status":"published-in-journal","subjectAreas":[{"id":53926696,"name":"Biological sciences/Biological techniques"},{"id":53926697,"name":"Biological sciences/Biotechnology"},{"id":53926698,"name":"Health sciences/Diseases"},{"id":53926699,"name":"Biological sciences/Genetics"},{"id":53926700,"name":"Biological sciences/Immunology"},{"id":53926701,"name":"Biological sciences/Microbiology"},{"id":53926702,"name":"Biological sciences/Molecular biology"}],"tags":[],"updatedAt":"2025-12-15T16:02:35+00:00","versionOfRecord":{"articleIdentity":"rs-7340318","link":"https://doi.org/10.1038/s41541-025-01304-9","journal":{"identity":"npj-vaccines","isVorOnly":false,"title":"npj Vaccines"},"publishedOn":"2025-12-13 15:58:04","publishedOnDateReadable":"December 13th, 2025"},"versionCreatedAt":"2025-09-01 16:35:59","video":"","vorDoi":"10.1038/s41541-025-01304-9","vorDoiUrl":"https://doi.org/10.1038/s41541-025-01304-9","workflowStages":[]},"version":"v1","identity":"rs-7340318","journalConfig":"researchsquare"},"__N_SSP":true},"page":"/article/[identity]/[[...version]]","query":{"redirect":"/article/rs-7340318","identity":"rs-7340318","version":["v1"]},"buildId":"8U1c8b4HqxoKbykW_rLl7","isFallback":false,"isExperimentalCompile":false,"dynamicIds":[84888],"gssp":true,"scriptLoader":[]}

Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.

My notes (saved in your browser only)

Ask this paper AI returns verbatim quotes from the full text · source: preprint-html

Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. This is a recent paper (2025) — citers typically take a year or two to land, and the OpenAlex reference graph may still be filling in.

Source provenance

europepmc
last seen: 2026-05-20T01:45:00.602351+00:00
unpaywall
last seen: 2026-05-28T02:00:01.590549+00:00
License: CC-BY-4.0